PTK2 and colorectal carcinoma: One study reported that the expression of CD155 is upregulated in 86.6% of patients with CRC, and that CD155 induces proliferation, migration, and invasion of CRC cells in vivo and in vitro by upregulating the expression of MMP2, FAK and Src (Figure 2A) [78].